Assessment of Acute Myeloid Leukemia for Expression of Tryptase and CD123 by Immunohistochemistry

被引:0
|
作者
Hatooglu, Medina [1 ]
O'Malley, Dennis [2 ]
机构
[1] NeoGen Labs Inc, Aliso Viejo, CA USA
[2] NeoGen Labs Inc, Dana Point, CA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1387
引用
收藏
页码:1307 / 1308
页数:2
相关论文
共 50 条
  • [1] Assessment of Acute Myeloid Leukemia for Expression of Tryptase and CD123 by Immunohistochemistry
    Hatooglu, Medina
    O'Malley, Dennis
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1307 - 1308
  • [2] Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia
    Nana Arai
    Mayumi Homma
    Maasa Abe
    Yuta Baba
    So Murai
    Megumi Watanuki
    Yukiko Kawaguchi
    Shun Fujiwara
    Nobuyuki Kabasawa
    Hiroyuki Tsukamoto
    Yui Uto
    Hirotsugu Ariizumi
    Kouji Yanagisawa
    Norimichi Hattori
    Bungo Saito
    Eisuke Shiozawa
    Hiroshi Harada
    Toshiko Yamochi-Onizuka
    Tsuyoshi Nakamaki
    Masafumi Takimoto
    [J]. International Journal of Hematology, 2019, 109 : 539 - 544
  • [3] Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia
    Arai, Nana
    Homma, Mayumi
    Abe, Maasa
    Baba, Yuta
    Murai, So
    Watanuki, Megumi
    Kawaguchi, Yukiko
    Fujiwara, Shun
    Kabasawa, Nobuyuki
    Tsukamoto, Hiroyuki
    Uto, Yui
    Ariizumi, Hirotsugu
    Yanagisawa, Kouji
    Hattori, Norimichi
    Saito, Bungo
    Shiozawa, Eisuke
    Harada, Hiroshi
    Yamochi-Onizuka, Toshiko
    Nakamaki, Tsuyoshi
    Takimoto, Masafumi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) : 539 - 544
  • [4] CD123 DIAGNOSTIC UTILITY IN ACUTE MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA
    Yang, Wayne
    Loriaux, Marc
    Gatter, Ken
    Braziel, Rita
    Huang, James
    Kelemen, Katalin
    Fan, Guang
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (06) : 376 - 376
  • [5] Immunohistochemical Expression of CD123 Is Associated with an Inferior Clinical Outcome in Acute Myeloid Leukemia
    Arai, Nana
    Saito, Bungo
    Abe, Maasa
    Watanuki, Megumi
    Murai, So
    Baba, Yuta
    Kawaguchi, Yukiko
    Fujiwara, Shun
    Tsukamoto, Hiroyuki
    Uto, Yui
    Kabasawa, Nobuyuki
    Yanagisawa, Kouji
    Hattori, Norimichi
    Homma, Mayumi
    Shiozawa, Eisuke
    Yamochi, Toshiko
    Takimoto, Masafumi
    Harada, Hiroshi
    Nakamaki, Tsuyoshi
    [J]. BLOOD, 2016, 128 (22)
  • [6] Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
    Ehninger, A.
    Kramer, M.
    Roellig, C.
    Thiede, C.
    Bornhaeuser, M.
    von Bonin, M.
    Wermke, M.
    Feldmann, A.
    Bachmann, M.
    Ehninger, G.
    Oelschlaegel, U.
    [J]. BLOOD CANCER JOURNAL, 2014, 4 : e218 - e218
  • [7] Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
    A Ehninger
    M Kramer
    C Röllig
    C Thiede
    M Bornhäuser
    M von Bonin
    M Wermke
    A Feldmann
    M Bachmann
    G Ehninger
    U Oelschlägel
    [J]. Blood Cancer Journal, 2014, 4 : e218 - e218
  • [8] Diagnostic and Prognostic Value of CD123 in Acute Myeloid Leukemia (AML)
    Eldin, Taghreed Kamal
    Abdelsalam, Eman M. Nagiub
    Razek, Ghadeer Abdel
    Nafady, Howaida
    Saleh, Mostafa F. Mohammed
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S272 - S273
  • [9] The study of expression and prognostic value of CD123 in acute myeloid leukemia bone marrow blasts
    岳文勤
    [J]. China Medical Abstracts (Internal Medicine), 2017, 34 (04) : 232 - 233
  • [10] CD123 expression linked to high-risk disease in children with acute myeloid leukemia
    不详
    [J]. CANCER, 2022, 128 (07) : 1357 - 1358